Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice.
about
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients.Application of Tissue Microarray Technology to Stem Cell Research.Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.
P2860
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Continuous tissue microarray b ...... in clinical routine practice.
@en
Continuous tissue microarray b ...... in clinical routine practice.
@nl
type
label
Continuous tissue microarray b ...... in clinical routine practice.
@en
Continuous tissue microarray b ...... in clinical routine practice.
@nl
prefLabel
Continuous tissue microarray b ...... in clinical routine practice.
@en
Continuous tissue microarray b ...... in clinical routine practice.
@nl
P2093
P2860
P356
P1476
Continuous tissue microarray b ...... in clinical routine practice.
@en
P2093
Alexander Stein
Carsten Bokemeyer
Eike Burandt
Fritz Jänicke
Guido Sauter
Jakob R Izbicki
Margit Fisch
Melanie Schreiber
Phillip R Stahl
Rainald Knecht
P2860
P304
P356
10.1002/GCC.22130
P577
2013-12-05T00:00:00Z